Skip to main content
Premium Trial:

Request an Annual Quote

Michael Levitt, Minoru Kanehisa, Steve Bryant, John Reed, William Strecker.

Premium

Structural Bioinformatics of San Diego has added Michael Levitt, professor and chair of computational structural biology at Stanford University School of Medicine, professor Minoru Kanehisa of Kyoto University, Steve Bryant at the US National Institutes of Health, and John Reed, head of research at the Burnham Cancer Research Institute in La Jolla, Calif., to its scientific advisory board.

Kanehisa’s laboratory develops theoretical frameworks for understanding information flow in biological systems in terms of genes, gene products, other biomolecules, and their interactions.

Bryant, a senior investigator at the US National Center for Biotechnology Information, has developed several databases and protein structure analysis tools, including Entrez/3D, MMDB, PKB, PDBeast, and a VAST-search tool.

William Strecker has left Compaq Computer of Houston to join life sciences and information technology venture creation firm NewcoGen Group of Cambridge, Mass., as senior vice president, strategy and technology. Strecker, who has 28 years of computer industry experience, will participate in creating and managing the company’s portfolio of high-technology start-ups.

Most recently Strecker had been Compaq’s senior vice president, technology and corporate development, and chief technology officer, where he reported to the CEO. He had held the same position at Digital Equipment before Compaq acquired it in 1998. Compaq recently made an investment in Applied Genomic Technology Capital Funds, a venture capital group formed by NewcoGen and OneLiberty Ventures.

Filed under

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.